Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
53,176,755
-
Share change
-
+675,747
-
Total reported value
-
$944,934,510
-
Price per share
-
$17.77
-
Number of holders
-
101
-
Value change
-
+$17,421,744
-
Number of buys
-
41
-
Number of sells
-
54
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2020
As of 31 Dec 2020,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,176,755 shares.
The largest 10 holders included
FMR LLC, BAUPOST GROUP LLC/MA, ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Chescapmanager LLC, STATE STREET CORP, GREAT POINT PARTNERS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.